Premium
Radiation therapy of seminoma of the testis
Author(s) -
Jose Baby,
Lee Perkins P.,
Kays Howard,
Chu Ann M.,
Sharma Subhash C.
Publication year - 1985
Publication title -
journal of surgical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.201
H-Index - 111
eISSN - 1096-9098
pISSN - 0022-4790
DOI - 10.1002/jso.2930280102
Subject(s) - medicine , seminoma , radiation therapy , general surgery , radiology , surgery , chemotherapy
This study is a review of 66 patients with a diagnosis of testicular seminoma, treated at the Department of Radiation Oncology, University of Louisville, from 1959 to 1978. Sixty‐four of the patients were diagnosed as pure seminomas and two as spermatocytic type. The age of the patients ranged from 16 to 75 years with a median of 39. Fifty‐four patients (82%) presented with swelling or mass in the testis, 7 patients with pain, 1 patient with hydrocele, and 4 patients had seminoma diagnosed incidentally. The distribution was equal for both right and left sides. There were 39 (59%) and 27 (41%) patients in stages I and II, respectively. All stage I patients received only infradiaphragmatic irradiation by a “hockey stick” field, and the majority of them received a dose of 3,200 – 3,600 rads in 3–4 weeks time. Stage II patients received elective irradiation to the mediastinum and neck region, in addition to the infradiaphragmatic irradiation. The 5‐year actuarial survival rates for stage I and II seminomas are 96% and 92%, respectively. There were no serious complications during follow‐up. The role of elective irradiation in stage I disease is discussed with a brief review of the literature.